Evidence map›Paper›PMID 34268287›Full record

SynthesisFrontiers in public health2021

Health-Related Quality of Life in Patients With Different Diseases Measured With the EQ-5D-5L: A Systematic Review.

Ting Zhou, Haijing Guan, Luying Wang, Yao Zhang, Mingjun Rui, Aixia Ma

2 registry-linked trialsAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Frontiers in public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 139 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed, 12 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07495254 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Effectiveness of Combined Super Inductive System (SIS) Therapy With Therapeutic Physical Therapy Exercise and Health Education in Lateral Elbow Tendinopathy

TypeinterventionalSponsorUniversity of Vic - Central University of CataloniaRan2026 to 2028Enrolled224ConditionsLateral Epicondylitis (Tennis Elbow), Lateral Epicondylalgia, Lateral Elbow TendinopathyArmsSuper Inductive System (SIS), therapeutic dose, Super Inductive System (SIS), non-therapeutic dose (active placebo), Therapeutic Exercise Program, Health Education
NCT07554508 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

A Prospective Registry for Belzutifan in the Treatment of Von Hippel-Lindau (VHL) Disease

TypeobservationalSponsorChinese University of Hong KongRan2026 to 2029Enrolled100ConditionsVHL - Von Hippel-Lindau Syndrome
3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 12 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Monitoring and evaluation instruments of individual health in community settings: a scoping review.Archives of public health = Archives belges de sante publique · 2026
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Health-related quality of life due to malaria: a systematic review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Trial
  14. Trial
  15. Is episodic future thinking effective in mitigating the influence of time preference in time trade-off?The European journal of health economics : HEPAC : health economics in prevention and care · 2025
    Trial
  16. Trial
  17. Trial
  18. Aphasia-specific or generic outcomes? a comparison of two health-related quality of life instruments for economic evaluations of aphasia treatments.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Trial
  19. Trial
  20. Trial

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ting ZhouSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Haijing GuanChina Center for Health Economic Research, Peking University, Beijing, China.
Luying WangSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Yao ZhangSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Mingjun RuiSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Aixia MaSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HIV InfectionsQuality of LifeCross-Sectional StudiesHumansReproducibility of ResultsSurveys and QuestionnairesdiseaseEQ-5D-5LEuroQolhealth utilityHRQOL

Identifiers

PMID34268287
PMCPMC8275935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.